Altered skeletal expression of sclerostin and its link to radiographic progression in ankylosing spondylitis

Abstract

Sclerostin expression is impaired in patients with AS, suggesting a specific alteration of osteocyte function in this disease. A low serum level of sclerostin in the setting of AS is linked to increased structural damage, emphasizing the role of sclerostin in the suppression of bone formation.